ConductScience.org, home

Gene · 2248

FGF3: fibroblast growth factor 3

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. FGF3: fibroblast growth factor 3. Genes, record 2248. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2248

On this page

Gene

Symbol
FGF3
HGNC
Name
fibroblast growth factor 3
HGNC
NCBI Gene ID
2248
NCBI Gene
HGNC ID
HGNC:3681
HGNC
Ensembl
ENSG00000186895
NCBI Gene
Aliases
HBGF-3, INT2
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P11487Fibroblast growth factor 32390Ensembl, GeneID, HGNC

Source UniProt

Patents122

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4705273 A22026-03-11211P11487Espacenet
EP 4650780 A22025-11-196078P11487Espacenet
JP 2025147176 A2025-10-065282P11487Espacenet
JP 2025529142 A2025-09-046375P11487Espacenet
US 12371689 B22025-07-296375P11487Espacenet
JP 2025517970 A2025-06-126078P11487Espacenet
JP 2025032204 A2025-03-1128383P11487Espacenet
JP 2025028160 A2025-02-285282P11487Espacenet
JP 2025013347 A2025-01-24211P11487Espacenet
KR 1020250010750 A2025-01-215282P11487Espacenet

1 to 10 of 122

See all 122 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,053

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFGF3 papersNewest fiscal year
P30CA016672Cancer Center Support Grant242025
P30CA008748Cancer Center Support Grant232025
P30ES010126UNC Center for Environmental Health and Susceptibility52025
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)42025
P30CA068485Cancer Center Support Grant42025
P30CA006927Comprehensive Cancer Center Program at Fox Chase32025
P30CA012197Cancer Center Support Grant32025
P30CA013330Cancer Center Support Grant32025
P30CA016086Cancer Center Support Grant32025
P30CA033572Cancer Center Support Grant32025

1 to 10 of 1,053Source NIH's project files

See all 1,053 nih grants

Papers2,103

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
An Accessible Approach to Molecular and Biomarker Testing for Risk Stratification in Oral Cavity Squamous Cell Carcinoma.Head Neck Pathol202642758366PubTator, text miningPubMed
Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions.Hum Pathol202642398544PubTator, text miningPubMed
Comparative Genomic Profiling and Prognostic Impact in Recurrent and/or Metastatic Hypopharyngeal and Esophageal Squamous Cell Carcinoma.Laryngoscope Investig Otolaryngol202642257210PubTator, text miningPubMed
Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/DD) and Pure Urothelial Carcinoma Using a Large-Scale Japanese Genomic Panel Dataset.Int J Urol202642252959PubTator, text miningPubMed
Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.Nat Med202642191879PubTator, text miningPubMed
A novel prognostic biomarker combining TP53 loss-of-function and amplification of different combinations of nine genes in lung squamous cell carcinoma treated with chemotherapy.Oncol Lett202642164467PubTator, text miningPubMed
ATRX loss in sarcomas is associated with dysregulated gene and transposable element expression, loss of DNA methylation, and worse survival.ESMO Rare Cancers202641994103PubTator, text miningPubMed
Molecular characteristics of proximal and distal esophagogastric junction adenocarcinoma.J Thorac Dis202641988313PubTator, text miningPubMed
Short-term response to alectinib and rapid progression in a lung squamous cell carcinoma patient harboring an EML4-ALK fusion: a case report.Transl Cancer Res202641969449PubTator, text miningPubMed
Research progress in heterogeneity of dental mesenchymal stem cells.Int J Oral Sci202641932866PubTator, text miningPubMed

1 to 10 of 2,103

See all 2,103 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2248

GET https://conductscience.org/api/genes/v1/2248/patents?page=2